Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells

被引:34
|
作者
Kallio, Anu [2 ,3 ]
Guo, Tao [2 ,4 ,5 ]
Lamminen, Elisa [2 ]
Seppanen, Jani [2 ]
Kangas, Lauri [6 ]
Vaananen, H. Kalervo [2 ]
Harkonen, Pirkko [1 ]
机构
[1] Lund Univ, MAS Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden
[2] Univ Turku, Inst Biomed, Dept Anat, FIN-20520 Turku, Finland
[3] Turku Grad Sch Biomed Sci, Turku, Finland
[4] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Wuhan 430022, Hubei, Peoples R China
[5] Lab Biotargeted Therapy Hubei Prov, Wuhan 430022, Hubei, Peoples R China
[6] Hormos Med Ltd, Turku, Finland
基金
芬兰科学院;
关键词
osteoblast; U2OS; estradiol; estrogen receptor; OPG; IL-6;
D O I
10.1016/j.mce.2008.03.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the current work, we compared the ability of 17 beta-estradiol (E-2) and the selective estrogen receptor modulators (SERMs), tamoxifen (Tam), raloxifene (Ral) and ospemifene (Osp) to promote the survival of osteoblast-derived cells against etoposide-incluced apoptosis. In order to compare the roles of the two estrogen receptor (ER) isotypes, we created a U2OS human osteosarcoma cell line stably expressing either ERalpha (ER alpha) or ERbeta (ER beta). Transfection with either of the ERs was able to render the U2OS cells sensitive to E-2. We show that E2 opposed etoposide-induced apoptosis and that the effect was mediated via both ER isotypes. The ER isotype selective agonists propyl-pyrazole-triol (PPT) and diarylpropionitrile (DPN) had the same effect in U2OS/ER alpha and U20S/ER beta cells, respectively. Osp also opposed apoptosis at least in U2OS/ERa cells. Tam and Ral were not able to protect against etoposide-induced cell death. In order to evaluate the protective effects of E-2 and Osp upon etoposide challenge, we studied the expression of two E-2-regulated, osteoblast-produced cytokines, IL-6 and OPG in E-2 and SERM-treated U2OS/ER alpha and U2OS/ER beta cells. Etoposide strongly increased expression of IL-6 and decreased that of OPG. E-2 opposed IL-6 increase only in U2OS/ER alpha cells and OPG decrease primarily in ER beta cells. Osp opposed the effect of etoposide on OPG primarily in U2OS/ER beta cells but interestingly, it had little effect on IL-6 expression. E2, PPT, DNP and Osp also inhibited etoposide-induced death and cytokine changes in SAOS-2 osteosarcoma cells expressing endogenous ER alpha and ER beta. Collectively, our results suggest that the osteoblast protective anti-apoptotic effects of E-2 are mediated by both ER alpha and ER beta but those of Osp primarily by ER alpha. In addition, E-2 and Osp opposed the etoposide-induced increase of IL-6 and decrease of OPG which changes would increase osteoclastic activity. These anti-resorptive effects of E-2 and Osp upon etoposide challenge differed from each other and they seemed to be differentially mediated in ER(x and ER beta expressing osteoblast-derived U2OS cells. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 50 条
  • [31] Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells
    Lv, Shu-Lan
    Wang, Rui
    Xue, Xue
    Zhao, Lan-Bo
    Tuo, Xiao-Qian
    Ma, Si-Jia
    Liang, Dong-Xin
    Wang, Yi-Ran
    Feng, Xue
    Li, Qing
    Wang, Qi
    Han, Lu
    Li, Qi-Ling
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5390 - 5400
  • [32] Effect of raloxifene (a Selective Estrogen Receptor Modulator (SERM)) as coadjuvant to antidepressant treatment: A case report
    Usall, Judith
    Coromina, Marta
    Araya, Susana
    Ochoa, Susana
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2011, 39 (05): : 334 - 335
  • [33] DT56a (Femarelle): A natural selective estrogen receptor modulator (SERM) for the management of menopause
    Yoles, Israel
    Somjen, Dalia
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (06): : 985 - 985
  • [34] SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) METABOLITES AND THEIR ACTIVITIES IN BREAST CANCER THERAPY: IMPLICATIONS FOR PRACTICE
    Braccia, Deborah
    Kaplan, Marcelle
    Lavender, Carolyn
    ONCOLOGY NURSING FORUM, 2013, 40 (06) : E422 - E422
  • [35] Chemopreventive effects of selective estrogen receptor modulator (SERM) raloxifene on intestinal neoplasia of APCMin/+ mice
    Janakiram, Naveena B.
    Mohammed, Altaf
    Qian, Li
    Venkateshwar, Madka
    Reddy, Manasa P.
    Steele, Vernon E.
    Rao, Chinthalapally V.
    CANCER RESEARCH, 2011, 71
  • [36] Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits
    Ozolins, TRS
    Gupta, U
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2004, 71 (03) : 161 - 170
  • [37] Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice
    Silva, L. A. S.
    Felix, F. B.
    Araujo, J. M. D.
    Souza, E. V.
    Camargo, E. A.
    Grespan, R.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2018, 51 (01)
  • [38] Protein modeling unravels the mysteries of selective estrogen receptor modulator (SERM)-like actions of Dilantin®.
    Fadiel, A
    Hamza, A
    Abu Shahin, F
    Song, J
    Edusa, V
    Naftolin, F
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 194A - 195A
  • [39] A selective estrogen receptor modulator (SERM) inhibits osteocyte apoptosis during estrogen loss. Implications for bone quality maintenance.
    Collishaw, S
    Mosley, J
    Taylor, C
    Reeve, J
    Noble, BS
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S293 - S293
  • [40] Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements
    Ball, Lonnele J.
    Levy, Nitzan
    Zhao, Xiaoyue
    Griffin, Chandi
    Tagliaferri, Mary
    Cohen, Isaac
    Ricke, William A.
    Speed, Terence P.
    Firestone, Gary L.
    Leitman, Dale C.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 299 (02) : 204 - 211